key: cord-0033838-t9tn6jdc
authors: nan
title: Oral Presentations 208–237
date: 2001
journal: Intensive Care Med
DOI: 10.1007/pl00003804
sha: 5c164d65f82685882c5bc7d7d6fab97d1e813c1d
doc_id: 33838
cord_uid: t9tn6jdc

nan

INTRODUCTION. Non-invasive mechanical ventilation (NIMV) with gas heliox (HE) have been recommended in acute COPD hypercapnic (1). METHODS. Aims: to compare effects during NIMV with two gases: heliox (HE) and oxygenair (O 2 -Air) in hypercapnic COPD exacerbation. Method: Face NIMV with BiPAP Vision (Respir, Inc.). Randomizated controlled method to apply gas (HE) or (O 2 -Air). RESULTS. Fifty COPD were enrolled. Dates at baseline (t = 0), 30 minutes (t = 1) and end therapy (t = 2) were analysed in 25 in two groups. Gas heliox mixtures: 72:28; UCI stay: 3.56 1 days (Heliox group) and 6.41 9.9 days (Air group) (p < 0.8). Success NIMV: Heliox 25/25, Air-Oxygen = 22/25. Skin no lesion 2/25 (heliox group) y 3/25 (Air group). METHODS. To avoid possible confounding effects, our analysis was focused only on COPD patients. 208 episodes of Acute Respiratory Failure (ARF) were analysed.

RESULTS. The rate of NIMV failure (death and intubation) progressively declined in the first 5 years from 29 % to 9 %. From '96 this rate was stabilised at around 17 %. A statistical analysis (change point test) allowed us to locate in '97 a significant change in the severity of admission pH (7.25 0.07 vs 7.20 0.08 for the years 92±96 and 97±99, respectively; p < 0.0001), while no differences were observed in the rate of failure (18 % vs 16 %). In the first 5 years period there was a significant difference in pH at admission between failure and success (7.21 0.06 vs 7.26 0.07; p < 0.003), but this was not the case after 96' (7.18 0.10 vs 7.21 0.08).

CONCLUSION. We conclude that the progressive learning and familiarity with NIMV of a dedicated team may 1) improve with time the patients' outcome 2) progressively allow to successfully treat more severe patients.

Antonelli M 1 , Conti G 1 , Pelosi P 2 , Gregoretti C 3 , Pennisi MA 1 , Costa R 1 , Recchioni G 1 , D'Amato L 1 , Munafò C 1 , Conti M 1 , Severgnini P 2 , Chiaranda M 2 . 1 Istituto di Anestesiologia e Rianimazione, Università Cattolica del Sacro Cuore, Rome, Italy, 2 Dipartimento di Scienze Cliniche e Biologiche, Università dell'Insubria, Varese, Italy, 3 Servizio di Anestesia e Rianimazione, Ospedale CTO, Torino, Italy

To assess the efficacy of noninvasive pressure support ventilation (NPSV) using a new special helmet as first line intervention to treat patients with hypoxemic acute respiratory failure (ARF), in comparison to NPSV using standard facial mask. Results of a prospective clinical pilot investigation with matched control group in three intensive care units of university hospitals are reported.

METHODS. Thirty-three consecutive non-COPD patients with hypoxemic ARF (defined as severe dyspnea at rest, respiratory rate > 30 breaths/min, PaO 2 :FiO 2 < 200, and active contraction of the accessory muscles of respiration) were enrolled. Each patient treated with NPSV by helmet was matched with two controls with ARF treated with NPSV via a facial mask, selected by SAPS II, age, PaO 2 /FiO 2 , and arterial pH on admission. Primary end points were the improvement of gas exchanges, the need for endotracheal intubation and the complications related to NPSV.

The 33 patients and the 66 controls had similar characteristics at baseline. Both groups improved oxygenation after NPSV. Eight patients (33 %) in the helmet group and 21 patients (32 %) in the facial mask group (P = 0.3) failed NPSV and were intubated. No patients failed NPSV due to intolerance of the technique in the helmet group in comparison with 8 patients (38 %) in the mask group (P = 0.047). Complications related to the technique (skin necrosis and gastric distension) were fewer in the helmet group compared to the mask group (no patients versus 10 patients(15 %), P = 0.013). Helmet allowed the continuous application of NPSV for a longer period of time (P = 0.05). Length of stay in the ICU, intensive care and hospital mortality were not different.

CONCLUSION. NPSV by helmet successfully treated hypoxemic ARF, with better tolerance and fewer complications than facial mask NPSV. Lactate is commonly used as fluid for replacement during hemofiltration since its metabolism results to an alkalinization. But lactate is also a useful substrate permitting to carry energy and reducing equivalent among cells and organs. The use of exogenous lactate as replacement fluid may interfere with its metabolism, therefore the aim of this study was to investigate lactate metabolism in acutely ill patients undergoing hemofiltration. METHODS. Seven patients (4M/3F, age = 51.7 7 y, 18±68) hospitalized in intensive care unit (APACHE II = 25 2.6, 16±37) and were assigned to receive at one day interval and in a random order bicarbonate (BICAR) or lactate (LAC) as fluid replacement during hemofiltration. Lactate metabolism was investigated in both situations by using an exogenous lactate challenge test (1): 2.5 mmol/kg body weight were infused during 15 min and plasma lactate concentrations (L) in the blood and in the ultrafiltrate were followed at T = 0, 4, 8, 12, 16, 20, 24, 30, 60, 90, 120 and 150 min after the end of the perfusion. Lactate clearance (LC), total lactate turnover (endogenous plus exogenous rates, TLT), lactate release in the ultrafiltrate (LR), endogenous lactate production (ELP), metabolized lactate ( 

Prostacyclin is a short-acting inhibitor of surface and shear stress induced platelet activation and is frequently used as a method of anticoagulation in continuous renal replacement therapies [1] . Where there is a coexistent coagulopathy or thrombocytopenia it is often the sole anticoagulant. Prostacyclin is absorbed onto the fibres of biocompatible membranes and therefore pre-filter administration may result in less platelet inactivation than if the drug were administered as a systemic intravenous infusion. This may in turn lead to shorter filter life and more pronounced thrombocytopenia. In order to address this question we have prospectively compared filter life and platelet count for both pre-filter and systemic intravenous administration of prostacyclin.

Over a four month period we studied a total of 142 haemofiltration episodes in 16 critically ill patients ( median Apache II score 13, interquartile range 14.5) with hepatic dysfunction and platelet counts of less than 50 x 109/L . Anticoagulation was provided with an infusion of epoprostenol 5 ng/kg/min (Glaxo Wellcome, Middlesex, UK) and each filter episode was randomised for the epoprostenol to be delivered either pre-filter or systemically. Patients did not receive any other anticoagulants or antithrombotics during the course of the study. Patients with proven heparin induced thrombocytopenic syndrome were not included in the study. Both groups were treated with hollow fibre polysulfone haemofilters (Baxter Healthcare Corporation, Irvine, CA, USA), predilutional fluid replacement, 2 L/h exchange volume with a blood flow rate of 180 mls/min. Comparisons between groups were made using the Mann-Whitney U Test.

RESULTS. There were 79 filter episodes in the pre-filter group and 63 in the systemic intravenous group. The median platelet count per filter episode was 34 x 109 /L in the pre-filter group and 45 x 109/L in the systemic group, P = 0.1495. The median filter life was 780 minutes in both groups, P = 1.00. (1). This might be explained by unpredictable interaction between DA1, b1, and a1-receptor-mediated effects. Thereby an a1-mediated vasoconstriction may counteract the desired DA1-mediated vasodilatation and thus prevent an increase of the microvascular oxygenation. Therefore, we examined the role of this a1-agonism for the inconsistent effects of DOP on the gastric microvascular oxygenation and compared its effects with those of fenoldopam (FEN), a novel selective DA1-receptor-agonist without a1-activity.

METHODS. 6 chronically instrumented dogs (flowprobes around the pulmonary artery for continuous cardiac output measurement) were repeatedly anaesthetised with permission of the local district government to study the relation between microvascular oxygenation of the gastric mucosa (mHbO 2 , tissue spectrophotometry) and systemic O 2 -delivery (DO 2 ). The following interventions were performed: DOP 2.5/5.0 mg/kg/min alone or after a1-blockade (prazosin), FEN 0.1/1.0 mg/kg/min alone or after DA1-blockade (SCH-23390, to exclude DA1-independent FEN-effects), and a control group (saline). The results are given as means sem. Statistics: ANOVA for repeated measurements, p < 0.05.

. DOP (alone and under a1-blockade) had on average no effect on mHbO 2 (56. INTRODUCTION. Endothelin-1 (ET-1) has been showed to be increased in cerebrospinal fluid (CSF) of patients which develop cerebral vasospasm or cerebral ischaemia. However it is not clear if it represents a marker or a mediator for vasospasm. We investigated the effects of CSF collected from 20 patients with subarachnoid hemorrhage (SAH) due to rupture of cerebral aneurysm on ET-1 production from human aortic endothelial cells (HAEC). METHODS. Patients were classified according to the angiographic evidence for vasospasm (day 7 post-hemorrhage) and a daily neurological evaluation (Glasgow Coma Score = GCS): no vasospasm (NV), angiographic vasospasm (AV = mild), clinical vasospasm (CV = severe), low GCS (neurological deterioration not due to vasospasm). CSF samples were collected daily, centrifuged at 3000 G for 5 minutes, and stored at ±80 C. HAEC (80±90 % confluence) were incubated for 6 hours with CSF from patients on day 4 post-hemorrhage (when vasospasm started to occur) or from normal subjects (control group). ET-1 was measured in the medium (ELISA) and normalised for total cell protein.

RESULTS. Patients were equally distributed according to the presence of vasospasm and other neurological sequelae. ET-1 levels in HAEC supernatants were 1.67 0.32, 1.66 0.54, 1.88 0.49, 1.76 0.45 and 2.165 0.79 fmol/mg (ET-1/tot prot, mean SD) in cells treated with CSF from control, NV, AV, CV and low GCS group respectively. Only the low GCS group showed a significant increase in ET-1 production compared to control (ANOVA p < 0.05). CONCLUSION. ET-1 production was significantly increased only in HAEC treated with CSF from low GCS patients who had already developed cerebral ischaemia on day 4 post-hemorrhage. However, there was no significant difference in ET-1 production in HAEC stimulated with CSF from patients with various degrees of vasospasm. These results suggest that ET-1 production may play a role in the early stages of neurological deterioration, and may be not responsible for the development of cerebral vasospasm in SAH patients. REFERENCE(S). INTRODUCTION. The aim of the study is to find the relationship between the grade of tricuspid regurgitation (TR) and accuracy of cardiac output (CO) measurement by thermodilution in mechanically ventilated patients.

METHODS. 27 non-cardiac surgery patients were separated into three groups. All patients were initially investigated by transesophageal echocardiography (TEE) (multiplanar probe, Omniplane, Hewlett-Packard) and later the pulmonary artery catheter (PAC) was inserted for continuing haemodynamic instability. All patients with higher than the 1 st degree of aortic regurgitation were excluded. There were 8 patients with no or the 1 st degree of TR graded according to color doppler criteria, the second group consisted of 9 patients with the 2 nd degree of TR. The third group included 10 patients with the 3 rd degree of TR. All patients were measured twice simultaneously by TEE and PAC for cardiac output. At least three pulsions were measured using continuous doppler for velocity-time integral (VTI) at the level of aortic valve and at least six VTI were averaged in case of stroke volume (SV) variation in atrial fibrilation. Aortic valve area (AVA) was measured by planimetry twice and results were averaged. SV was calculated multiplying VTI with AVA and heart rate (1,2). Simultaneous PAC measurement was carried out applying three 10 ccm boluses of iced saline.

The mean difference between TEE measurement and PAC measurement was 514.1 541.3 ml/min in the first group of patients (r = 0.96 p < 0.0001). The mean difference of 837.8 976.1 ml/min was found in the second group of patients (r = 0.92 p < 0.0001). The difference between the two modes of CO measurement was 1893.0 1143.9 ml/min in the third group (r = 0.69 p < 0.001).

CONCLUSION. The difference in the third group is probably caused by inadequately low values of CO measured by thermodilution. is known to be a highly effective therapy for terminating SVTA in medical patients its effectiveness in the treatment of SVTA in surgical intensive care patients has never been investigated. Therefore we studied effectiveness of DCC in 37 postoperative critically ill patients with newonset SVTA without any history of previous tachyarrhythmias.

METHODS. SVTA were defined as narrow-complex, non-sinus tachycardias with heart rates > 100 bpm for at least 15 minutes. In all patients a twelve lead ECG, arterial blood gas and serum electrolyte analysis were obtained before DCC. Serial creatine kinase MB isoenzyme determinations (three times within 24 hours) were performed. Demographic data including age, sex, weight, height, premorbidity factors, and admission SAPS-score as well as presence of SIRS with or without systemic infection were recorded from all patients. DCC was performed using a monophasic, damped-sinus-wave defibrillator. Energy levels used were 50, 100, 200 and 300 Joule (J) for regular SVTA and 100, 200, 360 J for irregular SVTA. Therapeutic effectiveness of DCC was followed for 48 hours. Demographic, premorbidity, laboratory data, presence or absence of SIRS with and without systemic infection were compared between patients responding to DCC and nonresponders using chi2-test, Fisher¢s exact test or Kruskal-Wallis one-Way Analysis of Variance. P-values < 0.05 were considered significant.

None of the patients experienced clinically relevant hypoxia (paO 2 < 60 mmHg), hypokalemia or hypomagnesemia at onset of SVTA. DCC restored sinus rhythm in 13 out of 37 patients (35 % primary responders). However, at 24 hours and 48 hours, only 6 (16 %) and 5 (13,5 %) patients remained in sinus rhythm, respectively. Primary responders were significantly younger and demonstrated significant differences in arterial pO 2 values and ionized calcium concentrations at onset of SVTA when compared with nonresponders. In the present study 24 patients (65 %) fulfilled the criteria of SIRS with and without infection before onset of SVTA.

In addition 29 patients (78 %) received catecholamine and/or phosphodiesterase inhibitor therapy.

CONCLUSION. In surgical intensive care patients DCC is an ineffective therapeutic method for successful long-term termination of new-onset SVTA. We speculate that differences in effectiveness of DCC between medical patients and surgical intensive care patients may result from major differences in the primary trigger mechanisms responsible for SVTA development. INTRODUCTION. The pathogenesis behind nosocomial infections in the intensive care unit (ICU) in particular ventilator-associated pneumonia (VAP) is still controversial. The aim of the present study were to assess the development over time and impact of oropharyngeal and gastric colonisation on the emergence of tracheal colonisation possibly leading to VAP in mechanically ventilated patients in a Swedish multidisiplinary ICU. Special emphasis was made on elucidating the role of anaerobic bacteria in the lower respiratory tract. METHODS. Consecutive patients (n = 41) requiring mechanical ventilation for more than 3 days were included. Patient characteristic were: median age 59 years (range 20±82), 15/41 were females. Median APACHE II score was 19, range 0±44, ICU mortality was 11/41. Ten of the patients had undergone transplantation, 32/41 patients had got at least one antibiotic before admission, 12/41 patients had clinical pneumonia at the time of admission. Samples were collected from oropharynx, subglottic space, trachea and stomach. The samples were collected after intubation and then every third day until day 33 or extubation. All samples were immediatly transported to the laboratory and frozen to ±70 C until analysed. RESULTS. Patients were heavy colonised ( > 60 % of samples) with microorganisms not considered belonging to a healthy normal gastric and oropharyngeal flora already at admission to the ICU. A majority of harboured enterococci, coagulase-negative staphylococci and candida spp. in at least one site on day 1. The patients were colonised with rather constant levels of microorganisms over time. Only in 4/41 an increasing concentration and in 9/41 a decreasing concentration over time in at least 50 % of the isolated species were found. An increasing load over time was associated with enterococci, gram-negative anaerobes and enterobacteriaceae. Decreasing levels occurred mainly in candida spp. We found anaerobes the majority were gram-negative, prevotella spp in subglottical and tracheal secret from day 12 to day 23 in a range between 40±100 % of all samples. Interestingly only one patient had pneumococci and one hemophilus influenzae species detected. One of the 41 patients developed VAP according to the criteria in the study. CONCLUSION. Patients in the ICU subjected to prolonged intubation showed a different pattern of colonisation as compared to the non-hospitalized population already at the time of admission to the unit. In some cases a colonisation pattern usually associated with long-stayers in the ICU was present from the start. In addition the presence of anaerobic species was high with a distribution also in the lower airways. This finding may be related to improved methodology in cultivating these strains. Obviously the colonisation pattern of ICU patients is variable over time as well as geographically. Therefore the relevance and applicability of literature reports for the individual unit must be interpreted with some caution. INTRODUCTION. Bacteria may gain entrance into the lung by several mechanisms.The major mechanism underlying the development of VAP seems to be (micro-) aspiration of potentially pathogenic microorganisms (PPM) (1). The aim of this prospective observational study was to describe and assess the relationship between oropharyngeal (OC), gastric (GC) and tracheal colonization (TC) patterns preceding VAP in surgical patients. METHODS. During a two years period,consecutive adult surgical patients at high risk for VAP and not receiving antimicrobials were studied.Quantitative cultures of endotracheal aspirates(ETA) reflecting TC were investigated daily, whereas oropharyngeal swabs and gastric aspirates were cultured in a qualitative manner, on admission and then thrice weekly until extubation. 

There is considerable debate about the relevance and even the existence of non-microbiologically documented (CD) ICU-acquired pneumonia (VAP). The goal of our study was to assess the incidence, relevance, impact and mortality of CD-VAP, compared to microbiologically documented (MD) ICU-acquired pneumonia.

METHODS. Retrospective analysis of prospectively collected data of all VAP occurring in a 12-bedded Intensive Care Unit of an Emergency Department of an University Hospital in Porto, from the 1 st January 1999 to the 31 st December 2000. The agreement of at least two senior intensivists in face of the clinical situation and of one senior intensivist acting as a reviewer of the clinical file was required for the diagnosis of VAP. MD-VAP was a pneumonia acquired more than 48 hours after admission to the ICU in which a plausible pathogen was isolated in bronchial secretions and/or blood cultures. In CD-VAP no plausible pathogen was found. Goal variables used to compare MD-and CD-VAP were: hospital mortality, ICU-mortality, mortality caused by VAP, day of VAP diagnosis, days of antibiotherapy, mechanical ventilation and ICU stay after VAP, success of the first empiric regimen and concomitant existence of another infection. Concomitant infections were defined as those diagnosed from day ± 2 to day 10 relating to VAP diagnosis. Statistical tests used were Chi-square and Mann-Whitney.

RESULTS. The results were as follows: CONCLUSION. MD-and CD-VAP seem to be similar in terms of all goal-variables studied and the existence of another infection concomitant with VAP is even more frequent in MDthan in CD-VAP. These two facts lead us to admit the existence and the clinical relevance of CD-VAP. INTRODUCTION. Risk factors for VAP vary from study to study and its impact on outcomes is controversial. Using data from a large, geographically diverse US inpatient database, we examined the incidence of and risk factors for VAP, as well as its effect on selected outcomes.

METHODS. Data were obtained for all patients admitted to an ICU from January 1998 to June 1999 who received mechanical ventilation for more than 24 hours. Patients were stratified based on whether they developed pneumonia at least 24 hours after intubation. The importance of potential risk factors for VAP was examined using crude and adjusted odds ratios. Cases of VAP were matched on age, duration of ventilation, type of admission, and severity of illness to up to 3 controls. Mortality, resource utilization, and billed charges were then compared between cases and controls.

A total of 9,080 patients were identified; 842 (9.3 %) had VAP. On average, VAP developed approximately 5 days after hospital/ICU admission. Patients with VAP were significantly (p < .05) younger and more likely to be male and admitted for trauma than those without VAP. Trauma admissions were nearly twice as likely to develop VAP as medical admissions (ad- CONCLUSION. This study, the largest of its kind, suggests that VAP is common and associated with adverse health and economic outcomes. Strategies to prevent this complication may yield significant benefits to the patient and the healthcare system.

Oral Presentations Liver failure and nutrition ± 228±232 INTRODUCTION. The refeeding syndrome refers to a complex metabolic phenomenon, which occurs following the re-introduction of carbohydrate-calories to acutely starved or chronically malnourished patients. Classically, it is marked by severe hypophosphatemia, but changes in potassium and magnesium may also be important.1 The aim of this study was to define the prevalence and incidence of refeeding syndrome-associated abnormalities in a large cohort of hospital based patients commenced on TPN.

METHODS. The Mater Misericordiae Hospital is a 510 bedded University Teaching Hospital, serving a population of 200,000 and it has a large tertiary referral practice. Between December 1989 and December 1997, 916 patients were commenced on in-hospital total parenteral nutrition. The set-up, delivery and monitoring of TPN was performed by a specialist Intravenous Nutrition Service consisting of a dedicated IV nutrition nurse and a consultant intensive care physician. Referral for TPN was made through the appropriate team caring for the patient, or directly as part of the multidisciplinary team in the intensive care unit. The Intravenous Nutrition Service reviewed the biochemical profile of patients individually and prescribed TPN (including electrolytes) electively five times per week. The database of the Intravenous Nutrition Service was interrogated. Serum phosphate, magnesium and potassium levels were recorded daily prior to and following commencement of TPN. A detailed record was kept of the daily TPN prescription and this included phosphate, magnesium and potassium levels in the bag and supplemental phosphate, magnesium or potassium received. Statistical analysis was performed using ANOVA and Chi square on SPSS for Windows (Version 10). Significance was assumed at the five-percent level. RESULTS. The mean phosphate level decreased significantly (P < 0.001) after commencement of TPN. The prevalence of hypophosphatemia was 18.9 % prior to commencing TPN. The incidence on day 1 was 9.3 % (P < 0.001). The mean potassium level decreased significantly (P < 0.001) after commencement of tpn. The prevalence of hypokalemia was 20 % prior to commencing TPN. The incidence on day 1 was 8.7 % (P < 0.001). The mean magnesium level was low prior to commencing TPN and increased significantly (P < 0.001) following the introduction of TPN. The prevalence of hypomagnesemia was 39.7 % prior to commencing TPN. The percent of patients with a low magnesium level decreased to 25.4 % on day 1 and to 6.0 % on day 2 after commencing TPN.

CONCLUSION. The prevalence of refeeding syndrome-associated biochemical abnormalities is high in hospitalised patients referred for TPN, but the incidence following the commencement of TPN is low. Hypomagnesemia was not a part of the refeeding syndrome following the introduction of TPN in the present study. This contasts with the pattern of refeeding hypophosphatemia and hypokalemia that were observed. The hypermetabolism in patients with severe head injuries results in malnutrition, impaired healing and an increased tendency to multiple organ failure (1). Thus, early and adequate nutritional support plays a crucial role in clinical outcome. The objectives of our study were to compare the ability of three different nutrition strategies to meet the caloric and protein requirements in severe head injury, and to study their effects on nitrogen balance. METHODS. 30 patients with GCS < 8 were randomly placed in enteral (EN) (n: 10), parenteral (PN) (n: 10) and combined enteral-parenteral nutrition (CN) (n: 10) groups. Targeted caloric intake was 30±35 kcal/kg/day nonprotein and 1.5 gr/kg/day protein. Nitrogen balance, biochemical laboratory analysis and the amount of caloric intake were evaluated daily. RESULTS. The demographic data of the patients were similar between the groups. The mean targeted caloric intake of the groups were 2195 400 kcal/day in enteral, 2280 175 kcal/day in parenteral and 2225 270 kcal/day in combined nutrition groups (p: 0.9) (Table 1. ). In enteral nutrition group, it took 5.3 1.6 days to reach targeted caloric amount, whereas balance periods of the targeted intake were shorter in parenteral (3.3 1 days) and combined nutrition (3 1 days) groups (p: 0.0003 when EN compared to PN and p: 0.001 when EN compared to CN). Nitrogen balance of enteral nutrition group on day 4 was lower than parenteral (p < 0.01) and combined (p < 0.01) nutrition groups. On day 10, there was no statistically significant difference between the nitrogen balance of three groups ( 

In critical ill patients glutamine becomes an essential amino acid with increased turnover and release from peripheral organs. This mechanism is supposed to play a major role in regulating catabolism in patients with septic shock. The aim of this study was to investigate the influence of a glutamine enriched total parenteral nutrition (TPN) on whole body catabolism in these patients.

A prospective randomised trial on 30 Patients who fullfilled the criteria of septic shock (ACCP/SCC) was performed. Patients were randomly assigned to receive 5 days of TPN with either a glutamine enriched amino acid solution for parenteral nutrition or an isonitrogenic isoenergetic standard amino acid solution ( 

Enteral feeding is often used in critically ill patients, gastrointestinal intolerance is probably the most important factor that limits its use. Our objective was to evaluate the relationship between enteral feeding tolerance and intra-abdominal pressure (IAP).

A total of 42 patients admitted to the intensive care unit (ICU) and receiving enteral nutrition were enrolled prospectively in the study, 32 had medical diseases and 10 had intraperitoneal abdominal surgery, all patients were followed until discharge from, or death in the ICU. Acute Physiology and Chronic Health Evaluation II (APACHE II) score, IAP and sagittal abdominal diameter (SAD) were recorded at admission. Every six hours we recorded: IAP,SAD, mL/h of administered diet,diarrhea,vomiting enteral formula,high gastric residuals ( > 200 mL/6 h), temporary stop of the infusion by intolerance, use of benzodiadiazepines, opiates and prokinetic agents .The patients outcome were also registered . In 37 patients the nasogastric tube was the method of feeding in 5 was a needle-catheter jejunostomy tube. Significant differences were assessed by Student's and chi-square tests . RESULTS. The first IAP before the beginning of the enteral feeding was 7.10 3.4 mmHg, the patiens with medical disease had an initial IAP of 6,1 2,9 mmHg, in the surgical patientes was 10,1 3,1 mmHg (p = 0,001).Admission APACHE II was 18.2 6.7 in medical patients and 13.7 4.0 in surgical patients ( p = 0,05).The SAD was 99 14 cm in medical patients and 103.1 13 cm in surgical patients (NS). High gastric residuals (58 %), diarrhea (28 %) and vomiting (12 %) are the main gastrointestinal complications (intolerance) . The patients (23) with everytime successful enteral feeding tolerance had a mean IAP of 5.1 2.3 mmHg, those with any episode of intolerance (19) had a mean IAP of 8.8 2.1 mmHg (p = 0.000). When the infusion was stopped a mean IAP of 10,4 1.8 mmHg was recorded, when wasn't the mean IAP was 5.1 2.3 mmHg (p = 0,000). In patients with any episode of intolerance (19), obviously there were episodes of right tolerance, in these episodes the mean IAP was of 6.7 1.9 mmHg, in patients with always successful tolerance the mean IAP was 5.1 2.3 mmHg (p = 0,02).The mL /hr of infused volume of diet were 39.9 18,9 mL in patients witn some determination of IAP over 10 mmHg and 61.9 17,6 mL in those with any under this IAP pressure (p = 0,000) The observed mortality rate was 28.6 % (12 patients), the mean IAP was 8.3 2.8 mmHg in deads and 6.2 2.6 mmHg in survivors (p = 0,03) .The enteral nutrition intolerance was higher in patients who died: 11 patients died among the 19 who intolerate diet compared with 1 dead among the 23 whit successful enteral feeding tolerance (chi2 test, p = 0,000). CONCLUSION. In critically ill patients there is a relationship between enteral feeding tolerance and IAP (the higher IAP the worse tolerance) .Enteral nutrition intolerance has a prognostic value in these patients. IAP could be an easy parameter to control the tolerance to enteral feeding .

TREATMENT INTRODUCTION. Severe Sepsis (SS) is the first cause of mortality in ICU 1 (Intensive Cardiology Care Units excluded). Severe Sepsis epidemiology evaluation is a priority to better understand its incidence, its physiopathology and new therapeutics strategies consequences.The purpose is to evaluate the SS epidemiology including mortality and morbidity over a large population of patients representing the Parisian area. METHODS. We prospectively recorded more than 100 000 ICU consecutive stays over a 7 year-period in 34 ICU (452 beds) of the Parisian area (65.7 % were university hospitals and 34.3 % other hospitals). Our study included all patients with a SS defined according to Bone's criteria 2 , with a length of stay > 2 days and admitted during a 3-year period (1997, 98, 99 Severe sepsis is one of the most challenging diseases requiring expensive procedures and drugs but its actual workload and total direct costs that may be evaluated by the Omega score are poorly defined. METHODS. We evaluated severe sepsis prognosis and resource consumption accordingly to the source of infection. Data were prospectively collected in 6 intensive care units in France from 1997 to 2000. Sepsis, severe sepsis, and septic shock were defined according to Bone's criteria (1). The intensity of care was measured accordingly to the daily use of invasive procedures and by the Omega score. This score describes 47 diagnostic and therapeutic weighted items measured either daily or once during the stay. It has been closely related to both workload and ICU costs (2) 

Fosse JP 1 , Bornstain C 1 , Thuong M 1 , Troche G 1 , Moine P 1 , Meshaka P 2 , Pinton P 2 , Timsit JF 1 . 1 OUTCOMEREA study group, DBIM Hôpital Saint Louis

António dos Capuchos, Lisboa, Portugal INTRODUCTION. Until now, in most studies, all patients with the acute respiratory distress syndrome (ARDS) have been analysed together. Although some studies have suggested that primary and secondary ARDS have different outcomes, it is usually considered that those different outcomes are depend from different severity of illness in both groups. The objective of this study is to compare the 28-days all cause mortality in patients with primary and secondary ARDS

Severity of illness as analysed by the APACHE II score (2) and the SAPS II score (3). The outcome measure used was vital status at 28 days. The Kaplan-Meier method was used to plot the survival curves for primary and secondary ARDS, and the log-rank test to compare the survival curves in the two populations

no differences where apparent in the baseline severity of illness, as measured by the APACHE II score (primary ARDS 24.53 6.76, secondary ARDS 25.98 11.94, p = 0.365) or by the SAPS II score (primary ARDS 52

At least in this sample, primary and secondary ARDS present a very different mortality at the 28-days in the ICU, which is not captured by general outcome prediction models such as the APACHE II and SAPS II

Of these, the Lung Injury Score (LIS), proposed by Murray et al. is the most commonly used (1). The objective of this work is to compare the LIS with two general outcome prediction models, the APACHE II (2) and the SAPS II (3) for risk

with a diagnosis of ARDS were studied (n = 142). The three instruments (LIS, APACHE II and SAPS II were computed according the original descriptions, using the worst values during the first 24 hours in the ICU. ARDS was defined according to the American-European Consensus Conference definitions (4)

Overall hospital mortality rate was 71.1 %). APACHE II and SAPS II presented significantly higher values in non-survivors than in survivors (APACHE II: 25.42 6.66 versus 17

At least in this sample, the performance of the general outcome prediction models (APACHE II and SAPS II) was significantly higher than the LIS. These results suggest that they should be used when we need to perform severity stratification in patients with ARDS. The exact role for disease-specific scores, such as the LIS

A new simplified acute physiology score (SAPS II) based on a European / North American multicenter study

INTRODUCTION. Stringent criteria for severe sepsis and sepsis shock have been defined to standardize studies. However they all lack of specificity and particularly in patients hospitalized in ICU for more than 48 hours since organ dysfunction and other criteria may occur independently of infectious processes. METHODS. We evaluated both morbidity and mortality associated with ICU-acquired severe sepsis (i. e. after the 48 th hour).Data were prospectively collected in 6 intensive care units (ICUs) in France from 1997 to 2000. Sepsis, severe sepsis, and septic shock were defined according to Bone's criteria (1). The intensity of care was measured accordingly to the daily use of invasive procedures and by the Omega score. This score describes 47 diagnostic and therapeutic weighted items measured either daily or once during the ICU stay (2). We distinguished 4 groups: (A) No severe sepsis (B) Severe sepsis on admission (C) Severe sepsis occurring beyond the first 48 hours (D) Patients presenting a severe sepsis episode on both admission and after the first 48 hours. Data are expressed as percent or as median [25 %±75 %] quartile. Variables were analyzed either by chi-square or by Kruskal Wallis test as needed. *, P < 0.0001 RESULTS. Secondary severe sepsis more frequently occurred in patients with severe sepsis on admission: 211/713 = 30 % vs. 128/985 = 13 % (P < 0.0001). The occurrence of severe sepsis after 48 hours was significantly associated with a higher ICU or hospital mortality and a higher resource consumption. This was observed whether or not the patient was initially admitted for severe sepsis. The total Omega score, which has been shown to closely correlate with the workload and direct cost of each stay(2), was also significantly higher in those patients.